| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $579.9M | +36.7% |
| Cost of Revenue | $59.7M | +15.5% |
| Gross Profit | $520.2M | +39.6% |
| R&D Expense | $200.8M | +28.6% |
| SG&A Expense | $150.4M | +27.5% |
| Operating Income | -$187.4M | +11.3% |
| Pre-tax Income | -$160.2M | +8.7% |
| Income Tax | $264.1M | +9011.7% |
| Net Income | -$424.2M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $288.0M | -2.5% |
| Accounts Receivable | $166.7M | +27.8% |
| Current Assets | $1.28B | +14.6% |
| Total Assets | $1.32B | +12.7% |
| Current Liabilities | $662.1M | +116.2% |
| Total Liabilities | $699.9M | +103.2% |
| Stockholders' Equity | $571.2M | -25.9% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $35.0M | +145.3% |
| Capital Expenditures | $1.6M | -73.7% |
| Investing Cash Flow | -$86.2M | +85.8% |
| Financing Cash Flow | $45.2M | -53.6% |
| Free Cash Flow | $33.4M | +140.1% |
| -146.2% |
| EPS (Basic) | -$2.75 | -137.1% |
| EPS (Diluted) | -$2.75 | -137.1% |